Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Betamethasone dipropionate - Generic Drug Details

« Back to Dashboard
Betamethasone dipropionate is the generic ingredient in eleven branded drugs marketed by Tolmar, Actavis Mid Atlantic, Schering, Taro, Fougera Pharms, Merck Sharp Dohme, Perrigo New York, Glenmark Generics, Pharmaderm, Savage Labs, Fougera, G And W Labs Inc, Teva, Promius Pharma Llc, Alpharma Us Pharms, Leo Pharma As, Perrigo Israel, and Glenmark Pharms, and is included in sixty NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has four patent family members in three countries.

There are sixty-six drug master file entries for betamethasone dipropionate. Twenty-one suppliers are listed for this compound.

Summary for Generic Name: betamethasone dipropionate

Drug Master File Entries: see list66
Suppliers / Packaging: see list21
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: betamethasone dipropionate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
betamethasone dipropionate; calcipotriene hydrate
OINTMENT;TOPICAL201615-001Jan 14, 2013RXNo► subscribe► subscribe
betamethasone dipropionate
CREAM;TOPICAL071476-001Aug 10, 1987DISCNNo► subscribe► subscribe
Promius Pharma Llc
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYes9,433,630► subscribeY ► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: betamethasone dipropionate

These historical archives are available as an add-on to one-year subscriptions.
See the Subscription Options for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
betamethasone dipropionate
GEL, AUGMENTED;TOPICAL019408-002Nov 22, 19914,489,070► subscribe
Merck Sharp Dohme
betamethasone dipropionate
CREAM, AUGMENTED;TOPICAL019555-001Apr 27, 19874,489,071► subscribe
betamethasone dipropionate
CREAM, AUGMENTED;TOPICAL019408-001Jan 31, 19864,482,539► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: betamethasone dipropionate

Country Document Number Estimated Expiration
Japan5833007► subscribe
World Intellectual Property Organization (WIPO)2011026076► subscribe
Japan2013503203► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.